阻塞性睡眠呼吸暂停低通气综合征与神经系统变性疾病的研究进展

doi:10.3969/j.issn.1004-583X.2026.02.013

摘要/Abstract

摘要：

睡眠呼吸中止症是一种普遍存在的疾病,其中最多见且被人熟知的类型是阻塞性睡眠呼吸暂停(obstructive sleep apnea hypopnea syndrome, OSAHS),尤其是在中年肥胖男性中。近年来有越来越多的专家指出,OSAHS可能与中枢神经系统变性疾病之间有密切关联。本文通过综述OSAHS在神经变性病中发生及进展过程中的影响及潜在机制,旨在为疾病治疗提供新角度。

关键词: 睡眠呼吸暂停, 阻塞性, 神经系统变性疾病, 间歇性缺氧, 氧化应激, 持续气道正压

中图分类号:

R563.8

唐亚赛, 杨凯琦, 孙楠, 董艳红. 阻塞性睡眠呼吸暂停低通气综合征与神经系统变性疾病的研究进展[J]. 临床荟萃, 2026, 41(2): 173-177.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.lchc.cn/CN/10.3969/j.issn.1004-583X.2026.02.013

https://www.lchc.cn/CN/Y2026/V41/I2/173

参考文献 51

[1]	中国医师协会睡眠医学专业委员会,中国医师协会神经内科医师分会睡眠学组. 中国成人失眠共病阻塞性睡眠呼吸暂停诊治指南(2024年)[J]. 中华全科医师杂志, 2025, 28(11):1289-1303.
[2]	Magnusdottir S, Hill EA. Prevalence of obstructive sleep apnea (OSA) among preschool aged children in the general population: A systematic review[J]. Sleep Med Rev, 2024,73:101871. doi:10.1016/j.smrv.2023.101871.
[3]	Bosi M, De Vito A, Eckert D, et al. Qualitative phenotyping of obstructive sleep apnea and its clinical usefulness for the sleep specialist[J]. Int J Environ Res Public Health, 2020, 17(6):2058. doi:10.3390/ijerph17062058.
[4]	Iannella G, Vicini C, Colizza A, et al. Aging effect on sleepiness and apneas severity in patients with obstructive sleep apnea syndrome: A meta-analysis study[J]. Eur Arch Otorhinolaryngol, 2019, 276(12):3549-3556. doi:10.1007/s00405-019-05616-0. pmid: 31482333
[5]	Pace A, Iannella G, Rossetti V, et al. Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis[J]. Medicina (Kaunas), 2020, 56(9):454. doi:10.3390/medicina56090454.
[6]	Magliulo G, Iannella G, Ciofalo A, et al. Nasal pathologies in patients with obstructive sleep apnoea[J]. Acta Otorhinolaryngol Ital, 2019, 39(4):250-256. doi:10.14639/0392-100X-2173. pmid: 30933181
[7]	Magliulo G, De Vincentiis M, Iannella G, et al. Olfactory evaluation in obstructive sleep apnoea patients[J]. Acta Otorhinolaryngol Ital, 2018, 38(4):338-345. doi:10.14639/0392-100X-1981. pmid: 30197425
[8]	Zaffanello M, Piacentini G, Sacchetto L, et al. Sleep-disordered breathing in children with rare skeletal disorders: A survey of clinical records[J]. Med Princ Pract, 2018, 27(5):451-458. doi:10.1159/000491391. pmid: 29929197
[9]	Shen Y, Qin H, Chen J, et al. Postnatal activation of TLR4 in astrocytes promotes excitatory synaptogenesis in hippocampal neurons[J]. J Cell Biol, 2016, 215(5):719-734. doi:10.1083/jcb.201605046. pmid: 27920126
[10]	Xu J, Du W, Zhao Y, et al. Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application[J]. Acta Pharm SinB, 2022, 12(6):2778-2789. doi:10.1016/j.apsb.2022.03.001.
[11]	牛小莉, 徐国栋. 内质网应激与中枢神经系统退行性疾病[J]. 河北医科大学学报, 2019, 40(3): 369-372. doi: 10.3969/j.issn.10073205.2019.03.029
[12]	李晓琼, 何玲玲. 自噬与中枢神经系统退行性疾病研究进展[J]. 中风与神经疾病杂志, 2018, 35(10): 953-935.
[13]	中华医学会神经病学分会痴呆与认知障碍学组. 阿尔茨海默病源性轻度认知障碍诊疗中国专家共识[J]. 中华神经科杂志, 2022, 55(5):421-440.
[14]	Uddin MS, Kabir MT, Rahman MS, et al. Revisiting the amyloid cascade hypothesis: From anti-aβ therapeutics to auspicious new ways for Alzheimer's disease[J]. Int J Mol Sci, 2020, 21(16):5858. doi:10.3390/ijms21165858.
[15]	Johnson ECB, Bian S, Haque RU, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease[J]. Nat Med, 2023, 29(8):1979-1988. doi:10.1038/s41591-023-02476-4. pmid: 37550416
[16]	Hampel H, Hardy J, Blennow K, et al. The amyloidβ pathway in Alzheimer's disease[J]. Mol Psychiatry, 2021, 26(10): 54815503. doi:10.1038/s41380021012490.
[17]	Mayer G, Frohnhofen H, Jokisch M, et al. Associations of sleep disorders with all-cause MCI/dementia and different types of dementia-clinical evidence, potential pathomechanisms and treatment options: A narrative review[J]. Front Neurosci, 2024, 18 Front Neurosci. doi: 10.3389/fnins.2024.1372326.
[18]	Cheng JX, Ren J, Qiu J, et al. Rapid eye movement sleep and slow wave sleep rebounded and related factors during positive airway pressure therapy[J]. Sci Rep, 2021, 11(1):7599. doi: 10.1038/s41598-021-87149-3.
[19]	Owen JE, Benediktsdottir B, Cook E, et al. Alzheimer's disease neuropathology in the hippocampus and brainstem of people with obstructive sleep apnea[J]. Sleep, 2021, 44(3):zsaa195. doi: 10.1093/sleep/zsaa195.
[20]	Kazim SF, Sharma A, Saroja SR, et al. Chronic intermittent hypoxia enhances pathological tau seeding, propagation, and accumulation and exacerbates alzheimer-like memory and synaptic plasticity deficits and molecular signatures[J]. Biol Psychiatry, 2022, 91(4):346-358. doi:10.1016/j.biopsych.2021.02.973.
[21]	Shiota S, Takekawa H, Matsumoto SE, et al. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-beta generation in mice[J]. J Alzheimers Dis, 2013, 37(2):325-333. doi: 10.3233/JAD-130419.
[22]	Bubu OM, Pirraglia E, Andrade AG, et al. Obstructive sleep apnea and longitudinal Alzheimer's disease biomarker changes[J]. Sleep, 2019, 42(6):zsz048. doi:10.1093/sleep/zsz048.
[23]	Sharma RA, Varga AW, Bubu OM, et al. Obstructive sleep apnea severity affects amyloid burden in cognitively normal elderly: A longitudinal study[J]. Am J Respir Crit Care Med, 2018, 197(7):933-943. doi: 10.1164/rccm.201704-0704OC.
[24]	Choe YM, Suh GH, Kim JW. Association of a history of sleep disorder with risk of mild cognitive impairment and Alzheimer's disease dementia[J]. Psychiatry Investig, 2022, 19(10):840-846. doi: 10.30773/pi.2022.0176.
[25]	Dickson DW. Neuropathology of parkinson disease[J]. parkinsonism relat disord, 2018, 46(Suppl 1):S30-S33. doi:10.1016/j.parkreldis.2017.07.033.
[26]	Liu QY, Yang M, Sheng YJ, et al. Clinical study of transcranial sonography image characteristics in patients with obstructive sleep apnea[J]. Sleep Breath, 2023, 27(4):1325-1332. doi:10.1007/s11325-022-02729-5.
[27]	Kurhaluk N, Kamiński P, Bilski R, et al. Role of antioxidants in modulating the microbiota-gut-brain axis and their impact on neurodegenerative diseases[J]. Int J Mol Sci, 2025, 26(8):3658. Published 2025 Apr 12. doi:10.3390/ijms26083658.
[28]	Bhandari UR, Danish SM, Ahmad S, et al. New opportunities for antioxidants in amelioration of neurodegenerative diseases[J]. Mech Ageing Dev, 2024,221:111961. doi:10.1016/j.mad.2024.111961.
[29]	Lord JS, Gay SM, Harper KM, et al. Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice[J]. Mol Autism, 2022, 13(1):35. doi:10.1186/s13229-022-00514-5. pmid: 36038911
[30]	Salsone M, Agosta F, Filippi M, et al. Sleep disorders and Parkinson's disease: Is there a right direction?[J]. J Neurol, 2024, 271(10):6439-6451. doi:10.1007/s00415-024-12609-5. pmid: 39133321
[31]	Yeh NC, Tien KJ, Yang CM, et al. Increased risk of parkinson's disease in patients with obstructive sleep apnea: A population-based, propensity score-matched, longitudinal follow-up study[J]. Medicine (Baltimore), 2016, 95(2):e2293. doi:10.1097/MD.0000000000002293.
[32]	Chen JC, Tsai TY, Li CY, et al. Obstructive sleep apnea and risk of Parkinson's disease: A population-based cohort study[J]. J Sleep Res, 2015, 24(4):432-437. doi:10.1111/jsr.12289.
[33]	Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems in the brain-implications for Alzheimer disease[J]. Nat Rev Neurol, 2015, 11(8):457-470. doi:10.1038/nrneurol.2015.119. pmid: 26195256
[34]	Taoka T, Naganawa S. Imaging for central nervous system (CNS) interstitial fluidopathy: Disorders with impaired interstitial fluid dynamics[J]. Jpn J Radiol, 2021, 39(1):1-14. doi:10.1007/s11604-020-01017-0.
[35]	Taoka T, Ito R, Nakamichi R, et al. Interstitial fluidopathy of the central nervous system: An umbrella term for disorders with impaired neurofluid dynamics[J]. Magn Reson Med Sci, 2024, 23(1):1-13. doi:10.2463/mrms.rev.2022-0012.
[36]	Menzies FM, Fleming A, Caricasole A, et al. Autophagy and neurodegeneration: Pathogenic mechanisms and therapeutic opportunities[J]. Neuron, 2017, 93(5):1015-1034. doi:10.1016/j.neuron.2017.01.022. pmid: 28279350
[37]	Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing[J]. Nat Rev Drug Discov, 2018, 17(9):660-688. doi:10.1038/nrd.2018.109. pmid: 30116051
[38]	Szûcs A, Mutti C, Papp A, et al. REM sleep, REM parasomnias, REM sleep behaviour disorder. REM-alvás, REM-parasomniák, REM-magatartászavar[J]. Ideggyogy Sz, 2022, 75(5-06):171-182. doi:10.18071/isz.75.0171. pmid: 35819343
[39]	Sateia MJ. International classification of sleep disorders-third edition: Highlights and modifications[J]. Chest, 2014, 146(5):1387-1394. doi:10.1378/chest.14-0970I.
[40]	Si X, Guo T, Wang Z, et al. Neuroimaging evidence of glymphatic system dysfunction in possible REM sleep behavior disorder and Parkinson's disease[J]. NPJ Parkinsons Dis, 2022, 29, 8(1):54. doi: 10.1038/s41531-022-00316-9.
[41]	Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration-an update[J]. Nat Rev Neurol, 2018, 14(1):40-55. doi:10.1038/nrneurol.2017.157.
[42]	Zhang JH, Fung SJ, Xi M, et al. Apnea produces neuronal degeneration in the pons and medulla of guinea pigs[J]. Neurobiol Dis, 2010, 40(1):251-264. doi:10.1016/j.nbd.2010.05.032.
[43]	Prineas JW, Parratt JD. Oligodendrocytes and the early multiple sclerosis lesion[J]. Ann Neurol, 2012, 72(1):18-31. doi:10.1002/ana.23634. pmid: 22829266
[44]	Aksenov DP, Rutila K, Li L, et al. Brain tissue oxygen and bold fMRI under different levels of neuronal activity[J]. Adv Exp Med Biol, 2023,1438:3-8. doi:10.1007/978-3-031-42003-0_1.
[45]	Sharma V, Verma R, Singh TG. Targeting hypoxia-related pathobiology in Alzheimer's disease: Strategies for prevention and treatment[J]. Mol Biol Rep, 2025, 52(1):416. Published 2025 Apr 23. doi:10.1007/s11033-025-10520-4. pmid: 40266407
[46]	Bhatia V, Sharma S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease[J]. J Neurol Sci, 2021,421:117253. doi:10.1016/j.jns.2020.117253.
[47]	Desai RA, Davies AL, Tachrount M, et al. Cause and prevention of demyelination in a model multiple sclerosis lesion[J]. Ann Neurol, 2016, 79(4):591-604. doi:10.1002/ana.24607. pmid: 26814844
[48]	Toubasi AA, Xu J, Eisma JJ, et al. Watershed regions are more susceptible to tissue microstructural injury in multiple sclerosis[J]. Brain Commun, 2024, 6(5):fcae299. doi:10.1093/braincomms/fcae299.
[49]	Ozturk B, Koundal S, Al Bizri E, et al. Continuous positive airway pressure increases CSF flow and glymphatic transport[J]. JCI Insight, 2023,8:e170270. doi: 10.1172/jci.insight.170270.
[50]	Oliver C, Li H, Biswas B, et al. A systematic review on adherence to continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) in individuals with mild cognitive impairment and Alzheimer’s disease dementia[J]. Sleep Med Rev, 2024,73:101869. doi: 10.1016/j.smrv.2023.101869.
[51]	Lajoie AC, Gu Y, Lim A, et al. Adherence to continuous positive airway pressure for the treatment of obstructive sleep apnea in neurodegenerative diseases: A systematic review[J]. Sleep Med Rev, 2023,71:101836. doi:10.1016/j.smrv.2023.101836.

阻塞性睡眠呼吸暂停低通气综合征与神经系统变性疾病的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 51

相关文章 15

编辑推荐

Metrics

本文评价

[1]	宋晨璐, 亓晓菁, 陈怿鹏, 邢广群. 不健康生活方式及吸烟与原发性膜性肾病的关系[J]. 临床荟萃, 2025, 40(6): 513-518.
[2]	张森, 张新生, 王东祥. 多层螺旋CT联合血清Vanin-1水平预测COPD患者预后的临床价值[J]. 临床荟萃, 2025, 40(4): 339-343.
[3]	温甜甜, 魏星, 马苗苗, 马丽群. 阻塞性睡眠呼吸暂停诱导残余胆固醇升高与冠心病机制及研究进展[J]. 临床荟萃, 2025, 40(11): 1035-1042.
[4]	周智明, 茹意, 李萍, 平芬. 多光谱照射联合常规治疗在慢性阻塞性肺疾病急性加重期患者中的临床应用[J]. 临床荟萃, 2025, 40(1): 27-32.
[5]	朱洁云, 高敏, 黄春莉, 潘冬赞, 王俏燕, 陆钊. 慢性阻塞性肺疾病再入院风险预测模型的系统评价[J]. 临床荟萃, 2024, 39(9): 773-779.
[6]	马苗苗, 王义艳, 温甜甜, 马丽群. 甘油三酯-葡萄糖指数与阻塞性睡眠呼吸暂停综合征相关性的研究进展[J]. 临床荟萃, 2024, 39(9): 851-854.
[7]	刘翠翠, 朱亚芳, 吕文娟. 不同HRCT表型COPD患者戒烟后肺功能、炎性因子和临床症状变化[J]. 临床荟萃, 2024, 39(7): 625-629.
[8]	马千里. 岩藻黄素在认知障碍类疾病中的研究进展[J]. 临床荟萃, 2024, 39(6): 572-576.
[9]	徐孟丹, 王礼琳. 阻塞性睡眠呼吸暂停与缺血性心肌病的关系研究进展[J]. 临床荟萃, 2024, 39(4): 357-362.
[10]	王沁濡, 尹琴, 李娟, 甘洪玉. 中医药治疗慢性阻塞性肺疾病合并肺动脉高压的研究进展[J]. 临床荟萃, 2024, 39(2): 188-192.
[11]	邵凯洋, 平芬, 张凤蕊. 膈肌起搏在慢性阻塞性肺疾病患者中的应用进展[J]. 临床荟萃, 2024, 39(12): 1131-1134.
[12]	梁祎. 姜黄素对2型糖尿病患者炎症及氧化应激影响的meta分析[J]. 临床荟萃, 2024, 39(11): 974-979.
[13]	朱玲珑, 黄微娜. 2014-2024年全球慢性阻塞性肺疾病微生态学文献计量分析[J]. 临床荟萃, 2024, 39(11): 1007-1015.
[14]	王琦, 陈宏. 维生素D在支气管哮喘和慢性阻塞性肺疾病治疗中的应用进展[J]. 临床荟萃, 2024, 39(1): 88-91.
[15]	李华, 陈建军, 未纪涛, 张旗. 血清胱抑素C水平与非阻塞性冠状动脉疾病的关系[J]. 临床荟萃, 2023, 38(9): 802-805.